Navigation Links
Baxa Corporation Announces 2011 Course Schedule for its STAR Center® Training Facility
Date:10/26/2010

ENGLEWOOD, Colo., Oct. 26 /PRNewswire/ -- Baxa Corporation, a leading provider of medical devices and systems that automate pharmacy operations, today announced the 2011 dates for its STAR (Skills Training, Academics and Resources) Center.  Located at the Baxa global headquarters in Englewood CO, the STAR Center furthers best practice in health-system pharmacy operations.  The ACPE-accredited 2011 curriculum offers participants hands-on training in a state-of-the-art cleanroom and pharmacy training facility.

2011 marks the third consecutive year that Baxa has partnered with USP to provide training in aseptic compounding activities at the STAR Center facility.  Professionals in the USP Council of Experts, Sterile Compounding Committee and other industry-leading faculty participate as instructors for the Aseptic Processing and Compliance Tools for USP 797 course.  

The STAR Center will offer the following courses in 2011:  

Aseptic Processing and Compliance Tools for USP 797

This two-and-a-half day training program benefiting pharmacy and IV managers covers facility and environmental requirements for compounding sterile products in compliance with USP 797.  Upon completion of the program, participants earn 21 hours of CE credits including one hour of law credit or 2.1 Continuing Education Units (CEUs).  The cost of attendance is $1,875 and the course will be offered three times: March 8-10; May 17-19; and Sept. 20-22, 2011.

Safe Handling and Preparation of Cytotoxic and Other Hazardous Drugs

Designed to educate pharmacists, technicians, nurses, nurse managers and physicians regarding best practices of safely preparing and handling hazardous drugs, this ten-hour course will be held three times in 2011.  Topics covered include engineering controls required for compounding hazardous drugs, proper use of closed-system drug transfer devices (CSDTDs), procedures for handling hazardous drug spills, hazardous waste containment and disposal, and regulatory compliance.  This program is approved for continuing education credits.  Visit the course page for specifics by attendee classification.  The cost of attendance is $995 and the course will be offered March 11; May 20; and Sept. 23, 2011.

Visit the STAR Center website to register or request additional information on the 2011 course schedule.

About the STAR CenterThe STAR Center is a state-of-the-art cleanroom, pharmacy and training facility located at the Baxa world headquarters in Englewood, Colorado.  The center was purpose-built to support training in aseptic technique, pharmacy workflow and practice, cleanroom design and maintenance and USP 797 compliance among other topics.  Classes are taught by industry-recognized subject matter experts.  Further information is available at http://starcenter.baxa.com/.

About USPThe United States Pharmacopeia (USP) is a scientific, nonprofit, standards-setting organization that advances public health through public standards and related programs that help ensure the quality, safety, and benefit of medicines and foods.  USP's standards are recognized and used worldwide.  For more information about USP visit http://www.usp.org.

About Baxa CorporationBaxa, a customer-focused medical device company, provides innovative, solution-based technologies for medication handling and delivery.  Its systems and devices promote the safe and efficient preparation, handling, packaging, and administration of medications.  Key products include the Abacus® Order Entry and Calculation Software, the DoseEdge™ Pharmacy Workflow Manager, ExactaMed® Oral Syringes, ExactaMix™ Automated Compounding Devices, InFuse™ and MicroFuse® Syringe Infusers, Repeater™ Pharmacy Pumps, NeoThrive® Enteral Syringes, the PadLock®  Set Saver and the RapidFill™ and IntelliFill® i.v. Automated Syringe Fillers; used worldwide in hospitals and healthcare facilities.  Privately held, Baxa Corporation has subsidiaries and sales offices in Florida, Canada and the United Kingdom; direct representation in Austria, Belgium, Denmark, Finland, France, Germany, Italy, Luxembourg, The Netherlands and Switzerland; and distribution partners worldwide.  Further information is available at www.baxa.com.Contact:Perrin McCormick or Brandie GerrishHB | Hart-Boillot: 781-893-0053Email: baxa@hartboillot.com
'/>"/>

SOURCE Baxa Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. United American Healthcare Corporation Names John M. Fife as Chairman of the Board
2. Cephalon Exercises its Option to Acquire BioAssets Development Corporation
3. CVS Caremark Corporation to Hold Third Quarter 2010 Conference Call
4. Luminex Corporation Third Quarter Earnings Release Scheduled for November 4, 2010
5. Cardiogenesis Corporation to Report 2010 Third Quarter Results on November 3rd
6. Physicians Pharmaceutical Corporation Offers Innovative On-Site Drug Dispensaries
7. Luminex Corporation Hosts Eighth Annual Planet xMAP Europe in Vienna
8. Tecan Group and Luminex Corporation Partner to Develop Automated Newborn Screening Solution
9. Arable Corporation Announces New Technology for Clinical Trial Industry
10. Kensey Nash Corporation Announces Its First Quarter Fiscal Year 2011 Earnings Release Date and Teleconference
11. Medical Simulation Corporation Signs Agreement With a Nationally Ranked Hospital
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2017)... 21, 2017 Halo Labs announces the launch ... analysis system called the Horizon at PEGS 2017 in ... new system analyzes sub visible particulate matter in biopharmaceutical ... screening as early as candidate selection and pre-formulation. ... contract research organization Elion Labs for system ...
(Date:4/20/2017)... April 20, 2017 Research and ... Biosimilar Pipeline and Market Prospects: Addressing Production Complexities Through ... their offering. ... "Global Biosimilar Pipeline and Market Prospects: Overcoming Production ... an in-depth assessment of the current trends in the ...
(Date:4/20/2017)... Inc ., a digital health company focused on modernizing and ... $25 million in Series B funding led by Qiming US ... Seattle that is part of a broader family ... included participation from SR One , who led ZappRx,s ... Google Ventures). As part of the financing, Mark McDade ...
Breaking Medicine Technology:
(Date:4/25/2017)... ... 25, 2017 , ... As President Trump challenges the status ... his administration could impact the employee benefits industry. James Slotnick, AVP, Government Relations, ... to make it through Congress. His discussion will focus on the current state ...
(Date:4/25/2017)... ... ... Lake Park Dental is now accepting new patients with crooked teeth who ... the help of this highly-effective, yet convenient system, patients can straighten their teeth and ... pain. , Drs. Sarah Jockin, Nicole Morganti, Sara Spear and Elizabeth Dy, of ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... ... the way in unveiling cutting-edge birth defects research related to Zika virus during ... the world’s premier society for this important science. , The Teratology ...
(Date:4/25/2017)... ... ... Chaudhary, MD is committed to providing the highest quality of spine care to all his ... with all my patients to alleviate possible future issues. I am pleased to have you ... and my trained staff will assist you in any way possible.” , Dr. Saad Chaudhary ...
(Date:4/25/2017)... Hollywood, Fl (PRWEB) , ... April 25, 2017 , ... ... than Memorial Regional Hospital, according to a special report in the May issue of ... Hospital its highest quality ranking for results achieved during and after coronary bypass ...
Breaking Medicine News(10 mins):